Aurobindo Pharma climbs about 2% on tentative USFDA nod for generic drug

NEW DELHI: Shares of Aurobindo Pharma climbed about 2 per cent in early trade on Tuesday, after the company received a tentative nod from the US Food and Drug Administration, the drug regulator, for its gNexium generic drug.

Reacting to the development, the scrip gained 1.46 per cent to hit a high of Rs 885 on BSE.